Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

18 Biggest Mid-Day Gainers For Friday

CNVS, NVDA, OCUL, RUN, HPE, MG, ITRI, DK, PLNT, NBY, JWN

 

  • Acacia Communications, Inc. (NASDAQ: ACIA) surged 32.5 percent to $89.72 following Q2 results. Acacia Communications reported quarterly non-GAAP earnings of $0.77 per share on revenue of $116.2 million. The company expects Q3 non-GAAP earnings of $0.64 to $0.76 per share, on revenue of $120 million to $128 million.
  • NovaBay Pharmaceuticals, Inc. (NYSE: NBY) shares climbed 30.4 percent to $3.20 following Q2 results. NovaBay Pharma reported a Q2 loss of $0.36 per share on revenue of $2.7 million.
  • Silicon Graphics International Corp (NASDAQ: SGI) shares climbed 28.8 percent to $7.70 after Hewlett Packard Enterprise Co (NYSE: HPE) announced plans to acquire the company for around $275 million.
  • Sunrun Inc (NASDAQ: RUN) shares climbed 17.4 percent to $6.35 as the company posted strong Q2 results.
  • Cosi Inc (NASDAQ: COSI) gained 16.7 percent to $0.262 following Q2 results. Cosi reported a Q2 loss of $0.07 per share on revenue of $22.8 million.
  • AveXis Inc (NASDAQ: AVXS) shares surged 14.6 percent to $39.87. AveXis posted a narrower-than-expected Q2 loss. Jefferies upgraded AveXis from Hold to Buy.
  • Eleven Biotherapeutics Inc (NASDAQ: EBIO) shares jumped 13.1 percent to $4.56. Eleven Biotherapeutics reported a Q2 loss of $0.33 per share on revenue of $0.3 million and issued a strategic update.
  • Cinedigm Corp (NASDAQ: CIDM) rose 12.2 percent to $2.12. Cinedigm is expected to report Q1 financial results on Monday, August 15, 2016.
  • InvenSense Inc (NYSE: INVN) gained 12.1 percent to $7.62. Pacific Crest upgraded InvenSense from Sector Weight to Overweight.
  • Planet Fitness Inc (NYSE: PLNT) shares climbed 10.1 percent to $22.39 as the company posted upbeat earnings for its second quarter on Thursday. The company raised FY 2016 revenue guidance to $366 million to $372 million, from $360 million to $370 million.
  • Ocular Therapeutix Inc (NASDAQ: OCUL) shares surged 10 percent to $6.93 after gaining 7.88 percent on Thursday.
  • Itron, Inc. (NYSE: ITRI) shares gained 9.1 percent to $47.65. Itron posted upbeat quarterly results.
  • Delek US Holdings, Inc. (NYSE: DK) shares gained 8.9 percent to $16.22. CVR Energy, Inc. is said to be planning to make an offer to acquire Delek US, according to sources as reported by the NY Post on Thursday. Carl Icahn owns a controlling stake in CVR and it thought to be building a stake in Delek, the sources said.
  • Nordstrom, Inc. (NYSE: JWN) shares surged 8.8 percent to $51.73 as the company reported better-than-expected earnings for its second quarter.
  • Mistras Group Inc (NYSE: MG) rose 7.6 percent to $24.55. Baird upgraded MISTRAS Group from Neutral to Outperform.
  • CVR Energy, Inc. (NYSE: CVI) gained 4.5 percent to $14.33. CVR Energy is said to be planning to make an offer to acquire Delek US, according to sources as reported by the NY Post on Thursday.
  • NVIDIA Corporation (NASDAQ: NVDA) shares rose 3.8 percent to $61.99 as the company reported stronger-than-expected Q2 results after market close on Thursday. NVIDIA saw Q3 revenues at $1.68 billion plus or minus 2 percent vs. estimates of $1.45. Additionally, management forecasted Q3 non-GAAP gross margins to be 58.0 percent.
  • J C Penney Company Inc (NYSE: JCP) rose 3.7 percent to $10.31 as the company reported a narrower-than-expected loss for the second quarter and reaffirmed its outlook for the full year 2016.


Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today